A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
This study has been completed.
First Posted: August 31, 2001
Last Update Posted: December 9, 2005
Information provided by:
NIH AIDS Clinical Trials Information Service